Explore 3 Stock Ideas & Industry Insights Download Free Report

General News

Top 5 Energy Producers by Revenue Growth: Viper Energy (NASDAQ:VNOM), Crescent Energy (NYSE:CRGY), Diamondback Energy (NASDAQ:FANG) and More

Five energy producers are ranked here by year-over-year revenue growth for the third quarter of 2026, using filings and releases from Nov 2, 2026, with one call held on Nov 3, 2026. Viper Energy (NASDAQ:VNOM) ranks first, with total operating income of $661 million, …

Vinay Lochav | 03 November 2026

Top 5 Fastest Revenue Growth: Aehr Test Systems (NASDAQ:AEHR), Lumentum (NASDAQ:LITE), Voyager Technologies (NYSE:VOYG) and More

Five companies that reported results on Nov 2, 2026 stand out for the pace of their year over year revenue growth, although their revenue bases differ widely. This list ranks them by reported growth, with rank 1 first.

Vinay Lochav | 03 November 2026

Top 5 Financial Revenue Growth Leaders: Ethos (NASDAQ:LIFE), EverQuote (NASDAQ:EVER), Paymentus (NYSE:PAY) and More

Five financial companies that reported around Nov 2, 2026 are ranked here by year-over-year revenue growth, fastest first. Four covered the third quarter ended Sep 30, 2026, whileCapitalSouthwest reported its fiscal second quarter of 2027 for the same period, using total investment income as …

Vinay Lochav | 03 November 2026

Top 5 Financial Net Income Leaders: Corebridge Financial (NYSE:CRBG), Equitable Holdings (NYSE:EQH), Loews (NYSE:L) and More

Five financial companies that reported third quarter 2026 results around Nov 2, 2026 are ranked here by as-reported net income, highest first. Corebridge Financial (NYSE:CRBG) ranks first at $1.44 billion, followed by Equitable Holdings (NYSE:EQH) at $1.121 billion, Loews (NYSE:L) at $306 million, CNA …

Vinay Lochav | 03 November 2026

Top 5 Healthcare Revenue Leaders: Vertex Pharmaceuticals (NASDAQ:VRTX), Jazz Pharmaceuticals (NASDAQ:JAZZ), IDEXX Laboratories (NASDAQ:IDXX) and More

Five healthcare companies that reported on Nov 2, 2026 are ranked here by third quarter revenue, with rank 1 being the largest. All figures are in U.S. dollars and cover the quarter ended Sep 30, 2026, though the companies sit on very different revenue …

Vinay Lochav | 03 November 2026

Top 5 Healthcare Revenue Growth Reporters: Recursion Pharmaceuticals (NASDAQ:RXRX), Syndax Pharmaceuticals (NASDAQ:SNDX), Hinge Health (NYSE:HNGE) and More

Five healthcare and biotech companies are ranked here by year-over-year revenue growth for the third quarter of 2026, with results released on Nov 2, 2026. Recursion Pharmaceuticals (NASDAQ:RXRX) ranks first at 258.5% (calculated), on revenue of $18.6 million against $5.2 million a year earlier. …

Vinay Lochav | 03 November 2026

Top 5 Healthcare Net Losses: Jazz Pharmaceuticals (NASDAQ:JAZZ), BioMarin (NASDAQ:BMRN), Recursion Pharmaceuticals (NASDAQ:RXRX) and More

Five healthcare companies posted the largest net losses in this group for the third quarter of 2026, with results released or filed on Nov 2, 2026. Ranked from the largest loss to the smallest, Jazz Pharmaceuticals (NASDAQ:JAZZ) reported a net loss of $483.4 million, …

Vinay Lochav | 03 November 2026

Health Tech Results: Which Platforms Grew Fastest, From Hinge Health (NYSE:HNGE), Tempus AI (NASDAQ:TEM), Waystar (NASDAQ:WAY) and More?

Five healthcare services and health technology companies reported third-quarter results for the period ended Sep 30, 2026, with revenue growth ranging from 7.1% to 52%. Four of the five reported on Nov 2, 2026, and Tactile Systems Technology discussed its results on a call …

Vinay Lochav | 03 November 2026

Markets Are Pricing In Political Gridlock, Not Just a Tech Correction

But the AI capex story does not fully account for what is happening in equity markets. There is a second, larger repricing underway, and it is political in nature. Markets are in the process of adjusting valuations to reflect the most probable outcome of …

Nitish Kishor | 03 November 2026

Why Is Penny Stock Zhengye Biotechnology (NASDAQ:ZYBT) Falling in Pre-Market With No Announcement in Sight?

We did not identify a press release, regulatory filing orEarningsreport from the company dated between October 30 and November 3, 2026 that would explain the decline. The move appears to be a continuation of the stock's history of sharp swings rather than a response …

Vinay Lochav | 03 November 2026
Support

Hi! How can we help you today?

Loading…